Compare ATRC & PCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | ATRC | PCT |
|---|---|---|
| Founded | 2000 | 2015 |
| Country | United States | United States |
| Employees | N/A | 174 |
| Industry | Medical/Dental Instruments | Environmental Services |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.6B | 1.5B |
| IPO Year | 2005 | N/A |
| Metric | ATRC | PCT |
|---|---|---|
| Price | $34.15 | $7.36 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 7 | 3 |
| Target Price | ★ $51.17 | $13.00 |
| AVG Volume (30 Days) | 1.1M | ★ 7.0M |
| Earning Date | 05-05-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 74.74 | N/A |
| EPS | N/A | N/A |
| Revenue | ★ $201,630,000.00 | N/A |
| Revenue This Year | $15.27 | $380.44 |
| Revenue Next Year | $12.21 | $203.33 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 15.40 | N/A |
| 52 Week Low | $25.36 | $4.93 |
| 52 Week High | $43.18 | $17.37 |
| Indicator | ATRC | PCT |
|---|---|---|
| Relative Strength Index (RSI) | 70.23 | 35.55 |
| Support Level | $34.16 | $5.02 |
| Resistance Level | $34.38 | $9.56 |
| Average True Range (ATR) | 1.50 | 0.49 |
| MACD | 0.62 | -0.04 |
| Stochastic Oscillator | 91.94 | 16.10 |
AtriCure Inc is an innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management, and post-operative pain management, and sells its products to medical centers through its direct sales force and distributors. Its product line includes Cryo, Soft Tissue Dissection, RF Ablation, Pacing and Sensing, and others. Geographically, it generates a majority of its revenue from the United States. Cardiac ablation and left atrial appendage management (LAAM) products are used by physicians during open-heart and minimally invasive surgical procedures. Pain management solutions are used by physicians to freeze nerves during cardiothoracic or thoracic surgical procedures.
PureCycle Technologies Inc is a Florida-based corporation focused on commercializing a patented dissolution process to physically separate the polymer from other plastics, color, and contaminants (the Technology), originally developed by The Procter & Gamble Company (P&G), for restoring waste polypropylene into resin with near-virgin characteristics, called PureFive resin. PureFive resin represents the family of recycled resin products produced, including ultra-pure resin and other grades used for compounding to meet customer specifications, which has similar properties and applicability for reuse as virgin polypropylene. It has a single operating segment, which encompasses integrated business activities related to the recycling of polypropylene into resins.